Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ARGX

Argen X SE ADR

Mar 26 • 09:38AM ET

586.95

Dollar change -18.57
Percentage change -3.07	%

Healthcare • Biotechnology • Netherlands • NASD

Peers: REGN VRTX BIIB INCY IONS GILD NBIX RCUS FGEN XBIT

| Held by: IBB CGGO FBT BBH QQQJ DFAI ONEQ FDG AVDE PFUT

Scroll to Statements

Index	-	P/E	46.01	EPS (ttm)	12.76	Insider Own	0.54%	Shs Outstand	60.76M	Perf Week	-5.33%
Market Cap	35.66B	Forward P/E	29.90	EPS next Y	19.63	Insider Trans	0.00%	Shs Float	60.44M	Perf Month	-6.08%
Income	831.41M	PEG	1.60	EPS next Q	2.24	Inst Own	56.00%	Short Float	3.69%	Perf Quarter	-5.91%
Sales	2.19B	P/S	16.31	EPS this Y	-6.96%	Inst Trans	-1.88%	Short Ratio	8.08	Perf Half Y	11.06%
Book/sh	90.49	P/B	6.49	EPS next Y	65.07%	ROA	15.48%	Short Interest	2.23M	Perf Year	45.76%
Cash/sh	55.61	P/C	10.55	EPS next 5Y	28.67%	ROE	17.33%	52W Range	352.77 - 678.21	Perf YTD	-4.56%
Dividend Est.	-	P/FCF	1318.41	EPS past 5Y	-	ROI	15.03%	52W High	-13.46%	Beta	0.59
Dividend TTM	-	Quick Ratio	6.68	Sales past 5Y	261.74%	Gross Margin	89.20%	52W Low	66.38%	ATR (14)	16.53
Dividend Ex-Date	-	Current Ratio	7.29	EPS Y/Y TTM	368.72%	Oper. Margin	-3.46%	RSI (14)	38.80	Volatility	2.00% 2.56%
Employees	1599	Debt/Eq	0.01	Sales Y/Y TTM	78.01%	Profit Margin	38.03%	Recom	1.33	Target Price	744.63
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-	Payout	0.00%	Rel Volume	1.75	Prev Close	605.52
Sales Surprise	9.39%	EPS Surprise	589.80%	Sales Q/Q	-	Earnings	Feb 27 BMO	Avg Volume	276.19K	Price	586.95
SMA20	-3.30%	SMA50	-7.08%	SMA200	4.83%	Trades		Volume	33,583	Change	-3.07%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-17-25	Upgrade	Bernstein	Mkt Perform → Outperform
Mar-12-25	Upgrade	Deutsche Bank	Sell → Hold
Jan-17-25	Downgrade	Deutsche Bank	Hold → Sell
Nov-12-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$697
Nov-05-24	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$715
Nov-01-24	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-24	Downgrade	Robert W. Baird	Outperform → Neutral	$515 → $650
Oct-10-24	Resumed	Raymond James	Strong Buy	$605
Oct-04-24	Downgrade	Deutsche Bank	Buy → Hold
Aug-06-24	Upgrade	Barclays	Equal Weight → Overweight
Jul-25-24	Upgrade	Deutsche Bank	Hold → Buy
Jul-23-24	Upgrade	Oppenheimer	Perform → Outperform	$546
Feb-15-24	Initiated	Wolfe Research	Peer Perform
Dec-20-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-20-23	Downgrade	Deutsche Bank	Buy → Hold
Jul-31-23	Initiated	Scotiabank	Sector Perform	$516
Jul-24-23	Downgrade	UBS	Buy → Neutral	$480 → $570
Jul-17-23	Resumed	Evercore ISI	Outperform	$436
Jun-15-23	Initiated	Societe Generale	Sell
May-31-23	Initiated	UBS	Buy	$480

Show Previous Ratings

Mar-24-25 01:56PM	Argenx: The Magic May Be Already Priced In (SeekingAlpha)
Mar-19-25 05:07PM	Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward (SeekingAlpha)
Mar-17-25 09:35AM	Argenx (ARGX) Surges 4.1%: Is This an Indication of Further Gains? (Zacks)
Mar-11-25 08:17AM	Artisan Small Cap Fund Sold argenx SE (ARGX) as it Exceeded Small-Cap Mandate (Insider Monkey)
Mar-07-25 01:00AM	argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting (GlobeNewswire)
04:50PM	Loading…
Mar-04-25 04:50PM	Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity (Investor's Business Daily)
Feb-28-25 09:24PM	Analyst Report: argenx SE (Morningstar Research)
Feb-27-25 01:00AM	argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update (GlobeNewswire)
Feb-25-25 01:00AM	argenx to Present at TD Cowen 45th Annual Healthcare Conference (GlobeNewswire)
Feb-21-25 04:58PM	These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50 (Investor's Business Daily)
Feb-20-25 01:00AM	argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 (GlobeNewswire)
Feb-19-25 10:58AM	Heres Why argenx SE (ARGX) Rose in Q4 (Insider Monkey)
07:10AM	Q4 2024 Halozyme Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-30-25 09:40AM	Is Argenx (ARGX) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-23-25 02:19AM	Is argenx SE (ARGX) the High Growth International Stock to Invest in Now? (Insider Monkey)
02:17AM	Loading…
02:17AM	Is Ascendis Pharma (ASND) the High Growth International Stock to Invest in Now? (Insider Monkey)
Jan-17-25 12:20PM	Earnings Estimates Rising for Argenx (ARGX): Will It Gain? (Zacks)
Jan-13-25 01:00AM	argenx Highlights 2025 Strategic Priorities (GlobeNewswire)
Jan-06-25 01:00AM	argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-28-24 06:28AM	Argenx Secures Japanese Approval for VYVDURA in CIDP Treatment (TipRanks)
Dec-27-24 01:00AM	argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (GlobeNewswire)
Dec-23-24 10:28AM	Is Argenx SE (ARGX) the Best Performing Biotech Stock in 2024? (Insider Monkey)
Dec-12-24 09:30AM	Heres Why argenx SE (ARGX) Surged in Q3 (Insider Monkey)
Dec-09-24 09:10AM	Should You Increase Your Holdings in argenx SE (ARGX)? (Insider Monkey)
Dec-02-24 02:55PM	Why Is Argenx SE (ARGX) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
Nov-26-24 01:00AM	argenx to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-22-24 05:30AM	Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial (BioPharma Dive)
Nov-20-24 01:00AM	argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies (GlobeNewswire)
Nov-18-24 09:10AM	Is argenx SE (ARGX) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-11-24 07:30AM	Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China (Business Wire)
07:30AM	Loading…
07:30AM	argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China (GlobeNewswire)
Nov-05-24 12:20PM	Why Argenx (ARGX) Might be Well Poised for a Surge (Zacks)
01:00AM	argenx to Participate at Upcoming Investor Conferences (GlobeNewswire)
Nov-02-24 10:40AM	Argenx price target raised to $660 from $540 at Truist (TipRanks)
Nov-01-24 03:06AM	argenx SE (ARGNF) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Challenges (GuruFocus.com)
Oct-31-24 03:39PM	Analyst Report: argenx SE (Morningstar Research) +6.27%
03:00PM	Here's Why You Should Hold Argenx SE (ARGX) (Insider Monkey)
02:00AM	argenx Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Oct-24-24 01:00AM	argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024 (GlobeNewswire)
Oct-16-24 10:29AM	Multiple Tailwinds Lifted argenx SE (ARGX) in Q3 (Insider Monkey)
Oct-15-24 01:00AM	argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions (GlobeNewswire)
Oct-09-24 03:14PM	argenx SE (ARGNF) Q2 2024 Earnings Call Highlights: Strong Financial Performance Amid ... (GuruFocus.com)
Oct-02-24 09:43AM	Biotech Leader Argenx In Buy Zone, Poised To Hit New Highs (Investor's Business Daily)
Sep-25-24 04:15PM	Amgen stock falls on lackluster drug data (Yahoo Finance Video) +5.63%
04:05PM	Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases (Investor's Business Daily)
Sep-19-24 01:00AM	argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy (GlobeNewswire)
Sep-12-24 10:09PM	Here's Why argenx SE (ARGX) Rose 9% in Q2 (Insider Monkey)
Sep-06-24 01:31PM	Four Biotech Stocks Rally Toward Buy Points As Funds Load Up (Investor's Business Daily)
08:39AM	Argenx (ARGX) Moves 4.0% Higher: Will This Strength Last? (Zacks)
Aug-29-24 12:29PM	Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB (Benzinga)
Aug-28-24 01:00AM	argenx to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-12-24 03:59PM	Biotech stocks: Which drugmakers are worth a buy? (Yahoo Finance Video)
Jul-30-24 12:00PM	Argenx (ARGX) Upgraded to Buy: Here's What You Should Know (Zacks)
Jul-25-24 08:30PM	Analyst Report: argenx SE (Morningstar Research)
01:00AM	argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update (GlobeNewswire)
Jul-18-24 01:00AM	argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 (GlobeNewswire)
Jul-16-24 07:04AM	What Made argenx SE (ARGX) Rise in Q2? (Insider Monkey)
12:30AM	argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China (GlobeNewswire)
12:15AM	Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China (Business Wire)
Jun-25-24 04:30PM	argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting (GlobeNewswire)
04:06AM	Argenx (ARGX) Surges 11.7%: Is This an Indication of Further Gains? (Zacks)
Jun-24-24 04:11PM	Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval (Investor's Business Daily) +11.69%
10:19AM	FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder (Zacks)
06:53AM	FDA approves argenxs VYVGART Hytrulo for CIDP treatment (Pharmaceutical Technology)
05:15AM	Argenx soars on CIDP shot approval (Investing.com)
Jun-21-24 04:50PM	argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (GlobeNewswire)
Jun-17-24 01:00AM	argenx to unveil its 'Vision 2030: Taking Breakthrough Science to 50,000 Patients' during its Upcoming R&D Day on July 16, 2024 (GlobeNewswire)
Jun-06-24 06:37PM	Analyst Report: argenx SE (Morningstar Research)
Jun-04-24 01:00AM	argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-30-24 04:02PM	After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay (Investor's Business Daily)
May-29-24 04:06PM	Biohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump (Investor's Business Daily)
10:17AM	Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump (Investor's Business Daily)
May-14-24 06:43PM	Analyst Report: argenx SE (Morningstar Research) +5.88%
May-13-24 10:30AM	JPMorgan Cuts Price Target on Argenx to $500 From $560, Maintains Overweight Rating (MT Newswires)
May-10-24 04:25PM	argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 12:28PM	Analyst Report: argenx SE (Morningstar Research)
06:52AM	ARGX Stock Earnings: argenx Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
01:00AM	argenx Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-08-24 10:56AM	Is a Surprise Coming for argenx (ARGX) This Earnings Season? (Zacks)
May-07-24 05:30PM	argenx announces results of Annual General Meeting of Shareholders (GlobeNewswire)
01:00AM	argenx to Present at BofA Securities 2024 Health Care Conference (GlobeNewswire)
May-02-24 06:42PM	Analyst Report: argenx SE (Morningstar Research)
01:00AM	argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 (GlobeNewswire)
Apr-16-24 01:00AM	argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease (GlobeNewswire)
Mar-29-24 04:42AM	Here's Why argenx SE (ARGX) Pulled Back 23% in Q4 (Insider Monkey)
Mar-27-24 02:00AM	argenx Advances Clinical Development of Efgartigimod in Primary Sjogren's Disease (GlobeNewswire)
Mar-26-24 04:00PM	argenx Announces Annual General Meeting of Shareholders on May 7, 2024 (GlobeNewswire)
02:00AM	argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia (GlobeNewswire)
Mar-22-24 10:28AM	Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday (Zacks)
07:47AM	Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last? (Zacks)
Mar-21-24 04:45PM	Argenx, Immunovant Soar As Tourmaline Plummets On A Rival's Lackluster Test Results (Investor's Business Daily) +11.19%
Mar-20-24 06:38PM	Analyst Report: argenx SE (Morningstar Research)
Mar-19-24 07:16AM	Reasons to Invest in argenx (ARGX) (Insider Monkey)
Mar-17-24 08:49AM	5 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-07-24 04:01PM	argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting (GlobeNewswire)
08:14AM	Ascendis Pharma A/S (ASND) Faced R&D Setbacks in Q4 (Insider Monkey)
07:28AM	Should You be Confident in Your Investment in argenx SE (ARGX)? (Insider Monkey)
Mar-01-24 10:12AM	argenx SE (NASDAQ:ARGX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 10:16PM	Analyst Report: argenx SE (Morningstar Research)
01:00AM	argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update (GlobeNewswire)

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ARGX

Argen X SE ADR

Upgrade your FINVIZ experience